top of page
21893.jpg

SERVICES

Solid Tumor Oncology


Solid tumour oncology deals with the treatment of solid tumours or solid cancers.
Solid cancers are malignant tumours, i.e. tumours that originated at one part of the body and then spread to different parts of the body. These tumours are abnormal masses of tissue that does not contain any cysts or liquid areas. Depending on the type of cells affected, they can be classified as sarcomas, carcinomas and many more. Solid cancers may occur in the bones, muscles or different organs.

14612.jpg
21893.jpg

Hemato- Oncology

Haemato-oncology involves studying and treating cancers of the blood, or Lymphatic Organs known as haematological cancers. The cells affected in Haematological disorders are mainly the RBC’s, WBC’s and / or platelets.
Haematological cancers are cancers that mainly affect the blood, bone marrow and lymph nodes. These cancers are either called leukaemia, lymphoma or myeloma, based on the type of blood cell that has been affected.

Bone Marrow Transplantation


Bone Marrow transplantation or Hematopoietic stem cell transplantation is a medical procedure performed to replace the bone marrow that has been damaged or destroyed by disease, hemotherapy or infection. This procedure involves transplanting blood stem cells, which travel to the bone marrow where they produce new blood cells and promote further growth of new marrow.

26590.jpg
32954.jpg

Preventive Oncology

Preventive oncology involves various measures taken to prevent the development of cancer in patients. This includes identifying causes and developing measures to remove or counteract them. The practice of prevention is dependent upon both individual efforts to improve lifestyle and seek preventive screening, and socioeconomic or public policy related to cancer prevention.
This could include implementing lifestyle changes pertaining to diet or physical activity. Some research supports that certain medications and vaccines could help reduce the risk of cancer. Another way of preventing cancer is by frequently screening for any signs of development of cancer, such as the presence of precancerous cells.

Dr (Col) Jasjit Singh 

MD & Fellowship Clinical Haematology & Bone Marrow Transplantation (BMT). (AIIMS, New Delhi)  

Senior Consultant & Head of Department 

Clinical Haematology &Bone Marrow Transplant ( BMT ) Graphic Era Institute of Medical Sciences, Dehradun

bottom of page